Onpattro and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Onpattro (patisiran), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vitamin A, and have Hereditary neuropathic amyloidosis.

The phase IV clinical study analyzes which people have Insomnia when taking Onpattro. It is created by eHealthMe based on reports of 2,785 people who have side effects when taking Onpattro from the FDA, and is updated regularly.

What is Onpattro?

Onpattro has active ingredients of patisiran. eHealthMe is studying from 2,785 Onpattro users. Check the latest studies of Onpattro.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,118 drugs and 5,169 conditions by eHealthMe. Check the latest studies of Insomnia.

On Jul, 14, 2026

2,785 people reported to have side effects when taking Onpattro.
Among them, 60 people (2.15%) have Insomnia.

Among these 60 people:

How long have people been on Onpattro when they have Insomnia? *

What is the gender of people who have Insomnia when taking Onpattro? *

female: 46.43 %
male: 53.57 %

What is the age of people who have Insomnia when taking Onpattro? *

What are other drugs people take besides Onpattro? *

What are other side effects people have besides Insomnia? *

Fatigue (feeling of tiredness): 16 people, 26.67%
Infusion Related Reaction: 13 people, 21.67%
Nausea (feeling of having an urge to vomit): 9 people, 15.00%
Weakness: 8 people, 13.33%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 11.67%
Pain In Extremity: 6 people, 10.00%
Pain: 6 people, 10.00%
High Blood Pressure: 5 people, 8.33%
Drowsiness: 5 people, 8.33%

What are the existing conditions these people have? *

Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 48 people, 80.00%
Amyloidosis Senile (common form of amyloidosis in very old people, usually mild and limited to the heart): 4 people, 6.67%
Amyloidosis (a tumour within which amyloid is produced): 2 people, 3.33%
Thyroid Diseases: 1 person, 1.67%
Sleep Disorder: 1 person, 1.67%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 1.67%
Neuropathy Peripheral (surface nerve damage): 1 person, 1.67%
Neuralgia (pain in one or more nerves): 1 person, 1.67%
Muscle Spasms (muscle contraction): 1 person, 1.67%
High Blood Pressure: 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Onpattro and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Onpattro:

Onpattro (2,785 reports)

Insomnia treatments and more:

Insomnia (438,078 reports)

Browse all side effects of Onpattro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,118 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,169 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on patisiran (the active ingredients of Onpattro) and Onpattro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.